Literature DB >> 20186614

Neurological disease produced by varicella zoster virus reactivation without rash.

Don Gilden1, Randall J Cohrs, Ravi Mahalingam, Maria A Nagel.   

Abstract

Reactivation of varicella zoster virus (VZV) from latently infected human ganglia usually produces herpes zoster (shingles), characterized by dermatomal distribution pain and rash. Zoster is often followed by chronic pain (postherpetic neuralgia or PHN) as well as meningitis or meningoencephalitis, cerebellitis, isolated cranial nerve palsies that produce ophthalmoplegia or the Ramsay Hunt syndrome, multiple cranial nerve palsies (polyneuritis cranialis), vasculopathy, myelopathy, and various inflammatory disorders of the eye. Importantly, VZV reactivation can produce chronic radicular pain without rash (zoster sine herpete), as well as all the neurological disorders listed above without rash. The protean neurological and ocular disorders produced by VZV in the absence of rash are a challenge to the practicing clinician. The presentation of these conditions varies from acute to subacute to chronic. Virological confirmation requires the demonstration of amplifiable VZV DNA in cerebrospinal fluid (CSF) or in blood mononuclear cells, or the presence of anti-VZV IgG antibody in CSF or of anti-VZV IgM antibody in CSF or serum.

Entities:  

Mesh:

Year:  2010        PMID: 20186614      PMCID: PMC3076592          DOI: 10.1007/82_2009_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  55 in total

1.  Retinal periphlebitis as zoster sine herpete.

Authors:  Y Noda; M Nakazawa; D Takahashi; T Tsuruya; M Saito; M Sekine
Journal:  Arch Ophthalmol       Date:  2001-10

2.  An unusual cause of trigeminal-distribution pain and tumour.

Authors:  Robert Hevner; Marcelo Vilela; Robert Rostomily; Randall Cohrs; Ravi Mahalingam; Mary Wellish; Donald H Gilden
Journal:  Lancet Neurol       Date:  2003-09       Impact factor: 44.182

3.  Intrathecal synthesis of virus-specific oligoclonal IgG, IgA and IgM antibodies in a case of varicella-zoster meningoencephalitis.

Authors:  F Vartdal; B Vandvik; E Norrby
Journal:  J Neurol Sci       Date:  1982 Nov-Dec       Impact factor: 3.181

4.  Zoster sine herpete causing acute trigeminal neuralgia.

Authors:  H G Easton
Journal:  Lancet       Date:  1970-11-21       Impact factor: 79.321

5.  Fatal massive hepatic necrosis from varicella-zoster hepatitis.

Authors:  J S Ross; W L Fanning; W Beautyman; J E Craighead
Journal:  Am J Gastroenterol       Date:  1980-11       Impact factor: 10.864

6.  Intrathecal synthesis of IgG antibodies to varicella-zoster virus in two cases of acute aseptic meningitis syndrome with no cutaneous lesions.

Authors:  P Martínez-Martín; A García-Sáiz; J L Rapún; J M Echevarría
Journal:  J Med Virol       Date:  1985-06       Impact factor: 2.327

7.  Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.

Authors:  P Ljungman; B Lönnqvist; G Gahrton; O Ringdén; V A Sundqvist; B Wahren
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

8.  Varicella-zoster virus acquired at 4 months of age reactivates at 24 months and causes encephalitis.

Authors:  Elena Chiappini; Giuseppe Calabri; Luisa Galli; Giuseppe Salvi; Maurizio de Martino
Journal:  J Pediatr       Date:  2002-02       Impact factor: 4.406

9.  Stress-induced subclinical reactivation of varicella zoster virus in astronauts.

Authors:  Satish K Mehta; Randall J Cohrs; Bagher Forghani; Gary Zerbe; Donald H Gilden; Duane L Pierson
Journal:  J Med Virol       Date:  2004-01       Impact factor: 2.327

10.  Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman.

Authors:  Ali A Habib; Don Gilden; D Scott Schmid; Joseph E Safdieh
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

View more
  57 in total

1.  Effect of time delay after necropsy on analysis of simian varicella-zoster virus expression in latently infected ganglia of rhesus macaques.

Authors:  Ravi Mahalingam; Vicki Traina-Dorge; Mary Wellish; Eileen Deharo; Anjani Golive; Ilhem Messaoudi; Don Gilden
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

2.  Zosteriform Morphea Without History of Herpes Zoster Infection.

Authors:  Hatice Ataş; Müzeyyen Gönül; Mehmet Koçak; Aysun Gökçe
Journal:  Arch Rheumatol       Date:  2016-08-01       Impact factor: 1.472

3.  THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

4.  Varicella Zoster Virus and Giant Cell Arteritis.

Authors:  Anne A Gershon; Michael Gershon
Journal:  J Infect Dis       Date:  2016-03-31       Impact factor: 5.226

5.  Clinical Reasoning: A 57-year-old woman with ataxia and oscillopsia: Varicella-zoster encephalitis.

Authors:  Michael J Bradshaw; Don Gilden; Patrick Lavin; Subramaniam Sriram
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

6.  Search for varicella zoster virus DNA in saliva of healthy individuals aged 20-59 years.

Authors:  Marius Birlea; Randall J Cohrs; Nathan Bos; Satish K Mehta; Duane L Pierson; Don Gilden
Journal:  J Med Virol       Date:  2013-11-06       Impact factor: 2.327

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  VZV multifocal vasculopathy with ischemic optic neuropathy, acute retinal necrosis and temporal artery infection in the absence of zoster rash.

Authors:  Marc Mathias; Maria A Nagel; Nelly Khmeleva; Philip J Boyer; Alexander Choe; Vikram D Durairaj; Jeffrey L Bennett; Naresh Mandava; Don Gilden
Journal:  J Neurol Sci       Date:  2013-01-11       Impact factor: 3.181

Review 9.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.